Hip Displacement in MECP2 Disorders: Prevalence and Risk Factors

Area of Science:

• Neurology
• Genetics
• Orthopedics

Background:

• Methyl-CpG binding protein 2 (MECP2) disorders, including Rett syndrome, cause severe neurological impairments.
• Hip displacement (HD) is a concern in MECP2 disorders, but its prevalence and risk factors are not well-established.
• This study investigates hip issues in MECP2 disorder patients.

Purpose of the Study:

• To determine the prevalence of hip displacement (HD) in patients with MECP2 disorders.
• To identify risk factors associated with the development of HD in this population.
• To inform the development of hip surveillance programs for MECP2 disorders.

Main Methods:

• Retrospective, comparative study of genetically confirmed MECP2 disorder patients.
• Prevalence of HD defined as migration percentage >30%.
• Analysis included age at onset, ambulatory status, scoliosis, seizures, and comorbidities.

Main Results:

• 36% of 56 patients (54 Rett syndrome, 2 MECP2 duplication syndrome) had HD, with onset at 7.7 years.
• Risk factors for HD included nonwalker status (P=0.04), scoliosis (P=0.001), and refractory epilepsy (P=0.04).
• HD prevalence is comparable to cerebral palsy and linked to disease severity.

Conclusions:

• Hip displacement is common in MECP2 disorders and associated with disease severity.
• Identifying risk factors like nonwalker status, scoliosis, and epilepsy is crucial.
• Findings support implementing hip surveillance programs for early management in MECP2 disorders.